Aeon, a Zurich-based preventive health company, has raised €8.2M in seed funding led by London VC Concentric. The funds will support expansion into Switzerland, Germany, and the UK, enhancing partnerships with insurers and employers for accessibility. Founded in 2023, Aeon utilizes AI in its health check-ups, merging whole-body MRI, blood analysis, and genetic testing to identify over 500 diseases early. This proactive approach addresses the growing concern of non-communicable diseases, which claim millions of lives yearly, primarily through preventable means.
Aeon is not just another testing solution. In our view, many consumer health products on the market today deliver questionable value, says Alex Stroud, Principal at Concentric.
Validated by insurers, Aeon is delivering the most medically robust preventive health product on the market. That rare combination of clinical rigor and commercial scalability is what makes this team so exciting.
Collection
[
|
...
]